These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 30737360)
41. MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis. Baba O; Hasegawa S; Nagai H; Uchida F; Yamatoji M; Kanno NI; Yamagata K; Sakai S; Yanagawa T; Bukawa H J Oral Pathol Med; 2016 Apr; 45(4):248-55. PubMed ID: 26307116 [TBL] [Abstract][Full Text] [Related]
42. CD73 is associated with poor prognosis in HNSCC. Ren ZH; Lin CZ; Cao W; Yang R; Lu W; Liu ZQ; Chen YM; Yang X; Tian Z; Wang LZ; Li J; Wang X; Chen WT; Ji T; Zhang CP Oncotarget; 2016 Sep; 7(38):61690-61702. PubMed ID: 27557512 [TBL] [Abstract][Full Text] [Related]
43. MiR-4295 facilitates cell proliferation and metastasis in head and neck squamous cell carcinoma by targeting NPTX1. Lu S; Zhou C; Zou B; Zhang H; Feng M Genes Immun; 2020 Jan; 21(1):4-12. PubMed ID: 31118494 [TBL] [Abstract][Full Text] [Related]
44. miR-204 inhibits angiogenesis and promotes sensitivity to cetuximab in head and neck squamous cell carcinoma cells by blocking JAK2-STAT3 signaling. Wu Q; Zhao Y; Wang P Biomed Pharmacother; 2018 Mar; 99():278-285. PubMed ID: 29353201 [TBL] [Abstract][Full Text] [Related]
45. miR-21 increases the programmed cell death 4 gene-regulated cell proliferation in head and neck squamous carcinoma cell lines. Sun Z; Li S; Kaufmann AM; Albers AE Oncol Rep; 2014 Nov; 32(5):2283-9. PubMed ID: 25175929 [TBL] [Abstract][Full Text] [Related]
46. FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma. Koole K; Brunen D; van Kempen PM; Noorlag R; de Bree R; Lieftink C; van Es RJ; Bernards R; Willems SM Clin Cancer Res; 2016 Aug; 22(15):3884-93. PubMed ID: 26936917 [TBL] [Abstract][Full Text] [Related]
47. RhoC mediates epidermal growth factor-stimulated migration and invasion in head and neck squamous cell carcinoma. Tumur Z; Katebzadeh S; Guerra C; Bhushan L; Alkam T; Henson BS Neoplasia; 2015 Jan; 17(1):141-51. PubMed ID: 25622907 [TBL] [Abstract][Full Text] [Related]
48. Network modeling identifies molecular functions targeted by miR-204 to suppress head and neck tumor metastasis. Lee Y; Yang X; Huang Y; Fan H; Zhang Q; Wu Y; Li J; Hasina R; Cheng C; Lingen MW; Gerstein MB; Weichselbaum RR; Xing HR; Lussier YA PLoS Comput Biol; 2010 Apr; 6(4):e1000730. PubMed ID: 20369013 [TBL] [Abstract][Full Text] [Related]
49. ANO1/TMEM16A interacts with EGFR and correlates with sensitivity to EGFR-targeting therapy in head and neck cancer. Bill A; Gutierrez A; Kulkarni S; Kemp C; Bonenfant D; Voshol H; Duvvuri U; Gaither LA Oncotarget; 2015 Apr; 6(11):9173-88. PubMed ID: 25823819 [TBL] [Abstract][Full Text] [Related]
50. DNA methylation regulated microRNAs in HPV-16-induced head and neck squamous cell carcinoma (HNSCC). Sannigrahi MK; Sharma R; Singh V; Panda NK; Rattan V; Khullar M Mol Cell Biochem; 2018 Nov; 448(1-2):321-333. PubMed ID: 29455435 [TBL] [Abstract][Full Text] [Related]
51. MicroRNA 744-3p promotes MMP-9-mediated metastasis by simultaneously suppressing PDCD4 and PTEN in laryngeal squamous cell carcinoma. Li JZ; Gao W; Lei WB; Zhao J; Chan JY; Wei WI; Ho WK; Wong TS Oncotarget; 2016 Sep; 7(36):58218-58233. PubMed ID: 27533461 [TBL] [Abstract][Full Text] [Related]
52. Regulation of microRNA expression by hepatocyte growth factor in human head and neck squamous cell carcinoma. Susuki D; Kimura S; Naganuma S; Tsuchiyama K; Tanaka T; Kitamura N; Fujieda S; Itoh H Cancer Sci; 2011 Dec; 102(12):2164-71. PubMed ID: 21899661 [TBL] [Abstract][Full Text] [Related]
53. Chemovirotherapy for head and neck squamous cell carcinoma with EGFR-targeted and CD/UPRT-armed oncolytic measles virus. Zaoui K; Bossow S; Grossardt C; Leber MF; Springfeld C; Plinkert PK; Kalle Cv; Ungerechts G Cancer Gene Ther; 2012 Mar; 19(3):181-91. PubMed ID: 22076043 [TBL] [Abstract][Full Text] [Related]
54. MicroRNA-375 Suppresses Extracellular Matrix Degradation and Invadopodial Activity in Head and Neck Squamous Cell Carcinoma. Jimenez L; Sharma VP; Condeelis J; Harris T; Ow TJ; Prystowsky MB; Childs G; Segall JE Arch Pathol Lab Med; 2015 Nov; 139(11):1349-61. PubMed ID: 26172508 [TBL] [Abstract][Full Text] [Related]
55. Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas. Hui AB; Lenarduzzi M; Krushel T; Waldron L; Pintilie M; Shi W; Perez-Ordonez B; Jurisica I; O'Sullivan B; Waldron J; Gullane P; Cummings B; Liu FF Clin Cancer Res; 2010 Feb; 16(4):1129-39. PubMed ID: 20145181 [TBL] [Abstract][Full Text] [Related]
56. Epidermal growth factor receptor variant III in head and neck squamous cell carcinoma is not relevant for targeted therapy and irradiation. Thomas Koch D; Pickhard A; Gebel L; Buchberger AMS; Bas M; Mogler C; Reiter R; Piontek G; Wirth M Oncotarget; 2017 May; 8(20):32668-32682. PubMed ID: 28427242 [TBL] [Abstract][Full Text] [Related]
57. Emerging Role of miR-372 and miR-101a in Head and Neck Squamous Cell Carcinoma. Moradi N; Fadaei R; Haqgou M; Barez SR; Kargasheh FB; Shanaki M; Dilmaghani NA Clin Lab; 2020 Apr; 66(4):. PubMed ID: 32255289 [TBL] [Abstract][Full Text] [Related]
58. MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma. Avissar M; Christensen BC; Kelsey KT; Marsit CJ Clin Cancer Res; 2009 Apr; 15(8):2850-5. PubMed ID: 19351747 [TBL] [Abstract][Full Text] [Related]
59. MicroRNA-3666 Suppresses Cell Growth in Head and Neck Squamous Cell Carcinoma Through Inhibition of PFKFB3-Mediated Warburg Effect. Chen L; Cao Y; Wu B; Cao Y Onco Targets Ther; 2020; 13():9029-9041. PubMed ID: 32982293 [TBL] [Abstract][Full Text] [Related]
60. miR-204 enhances p27 mRNA stability by targeting Brd4 in head and neck squamous cell carcinoma. Wang C; Zhang Y; Zhou D; Cao G; Wu Y Oncol Lett; 2018 Oct; 16(4):4179-4184. PubMed ID: 30250532 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]